Antibody Industry, March 2015 Market Reports from Top Publishers

You might be interested in: disease testing, flow cytometry, diagnostic, hematology, therapeutics, medical equipment, microbiology, hemostasis, cancer, blood typing, coagulation, blood banking, nucleic acid testing, drug, biosimilar.


 
1-10 of about 200 reports for Antibody

Antibody Deals and Alliances of 2014

Antibody Deals and Alliances of 2014

  • $ 1 495
  • Industry report
  • March 2015
  • by Currentpartnering

The Antibody Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

Competitor Analysis: Specific and Bispecific Her3 Antibodies

Competitor Analysis: Specific and Bispecific Her3 Antibodies

  • $ 275
  • Industry report
  • February 2015
  • by La Merie Publishing

Competitor Analysis: Specific and Bispecific Her3 Antibodies This Competitive Intelligence Report about Specific and Bispecific Her3 Antibodies provides a competitor evaluation in the field of recombinant ...

Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin

Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin

  • $ 412
  • Industry report
  • February 2015
  • by La Merie Publishing

Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin This Competitive Intelligence Report about Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin provides ...

Competitor Analysis: VEGF & VEGF-R Antibodies 2015 - Biosimilars and Biosuperiors of Avastin and Lucentis

Competitor Analysis: VEGF & VEGF-R Antibodies 2015 - Biosimilars and Biosuperiors of Avastin and Lucentis

  • $ 486
  • Industry report
  • February 2015
  • by La Merie Publishing

Competitor Analysis: VEGF & VEGF-R Antibodies 2015 - Biosimilars and Biosuperiors of Avastin and Lucentis This Competitive Intelligence Report about VEGF and VEGF-R Antibodies 2015 - Biosimilars and ...

Global Markets for Research Antibodies

Global Markets for Research Antibodies

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for research antibodies reached $2 billion in 2013 and nearly $2.2 billion in 2014. This market is expected to reach nearly $3 billion in 2019, registering a compound ...

Hycor Biomedical Inc. - Medical Equipment - Deals and Alliances Profile

Hycor Biomedical Inc. - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2015
  • by Global Data

Summary Hycor Biomedical Inc. (Hycor) is an in vitro diagnostics products manufacturer and marketer. The company manufactures and markets systems and testing products for in vitro allergy and autoimmune ...

Biosimilar Monoclonal Antibodies: World Industry and Market Outlook 2015-2025

Biosimilar Monoclonal Antibodies: World Industry and Market Outlook 2015-2025

  • $ 2 766
  • Industry report
  • January 2015
  • by Visiongain

Report Details Biosimilar therapeutic antibodies - see why originator companies should now fear those competitors, discovering their trends and potential sales What's the future of biosimilar antibody ...

Antibodies in Oncology: Drug Pathway Analyzer 2015

Antibodies in Oncology: Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 701 antibody drugs known to affect more than 213 specific intracellular signaling pathways for the treatment ...

Abnova Corporation (Symbol:4133) SWOT Analysis, Strategy, Revenues and Profits

Abnova Corporation (Symbol:4133) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Innate Pharma SA (Symbol:IPH) SWOT Analysis, Strategy, Revenues and Profits

Innate Pharma SA (Symbol:IPH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

About 3 700 reports for Antibody

Download Unlimited Documents from Trusted Public Sources

Sanofi Annual Report 2013

  • January 2013
    193 pages
  • Common Stock  

    Equity Market  

    Antibody  

  • United States  

View report >

2 Companies for Antibody

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Biogen Idec

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.